Next-generation molecular testing for monitoring viral load
The Need
Measurement of blood plasma HIV-1 RNA using PCR is established as the standard of care in assessing HIV-positive patient prognosis and response to antiretroviral therapy
It is estimated that only 75% of people living with HIV worldwide have access to viral load testing. In Low and Middle-Income Countries (LMICs), this figure is below 50%1
HIV viral load tests that can be deployed beyond centralized laboratories are needed to expand access to the standard of care1
1 Malisa et al 2023 Nature Scientifc Reports | (2023) 13:4578 | https://doi.org/10.1038/s41598-023-31103-y
The Solution
The Xpert HIV-1 Viral Load XC test is an on-demand quantitative PCR test incorporating dual target detection for extended strain coverage
Using GeneXpert® technology, the Xpert HIV-1 Viral Load XC test automates the test process in one fully integrated cartridge and enables testing in laboratory or near‑patient testing environments
Provides users with advantages of simple workflow, fast results, and flexibility for low-to-high volume testing
Xpert® HIV‑1 Viral Load XC is intended to be performed by trained professional users or trained healthcare workers in laboratory or near-patient testing environments.
The Impact
Support streamlined care pathways with fast sample collection and result availability